{"version":"1.0","type":"link","title":"Validation of \"SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade\" in an independent cohort of 4,407 patients.","author_name":"Arbel R 외","author_url":"https://prs-insight.online/author/Arbel%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94270","thumbnail_width":1200,"thumbnail_height":630}